Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Efficacy and Safety of Direct Acting Agents in Hepatitis C Patients

NCT03145844 is registered in ClinicalTrials.gov with Fehmi Tabak as lead sponsor.

NCT NCT03145844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03145844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Efficacy and Safety of Direct Acting Agents in Hepatitis C Patients
Lead sponsor
Fehmi Tabak
Phase
Observational
Overall status
Completed
Start date
April 9, 2017
Completion date
December 31, 2018
Enrollment
2,700 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, hepatitis c recurrent, hepatitis c relapse